Podcasts about Uber

In this special Market Mondays clip, the hosts dive deep into why Uber might just be the sleeper stock of the decade. Troy Millings breaks down his bullish long-term view on Uber, especially as the company stands to benefit from the coming wave of autonomous vehicles. With competitors like Waymo pushing into new markets and the constant talk around Tesla and robo-taxis, is Uber's powerful platform and trusted brand its ultimate edge?The conversation unpacks how autonomous vehicle partnerships could revolutionize Uber, especially as driver costs are the biggest expense for the company. Food delivery isn't left out—imagine a world where your meals arrive without a driver, putting even more revenue right into Uber's pocket.Ian Dunlap and Rashad Bilal join in to discuss Uber's recent stock performance, its impressive turnaround from the low $20s in 2022, and why the company isn't even at $100 per share yet. They touch on Uber's competition with Lyft, the fallout from the old Uber vs. Google/Waymo lawsuit, and why Uber remains the household name despite the ride-sharing wars.If you're curious about investing strategies, Troy also breaks down *leap options*: what they are, why he prefers to go out as far as possible (sometimes 2–3 years ahead), and how deep-in-the-money strikes can maximize gains while minimizing risk. He throws in a reference to how prominent figures like Nancy Pelosi use similar long-term option strategies for major blue-chip stocks, and explains his personal approach to playing Uber for the long game.Whether you're an investor in the tech space, a fan of finance news, or you just want the inside scoop on where ride-sharing and delivery is heading, this clip packs actionable insight you won't want to miss.*Topics covered:* Uber's potential in autonomous vehicles The competition (Waymo, Lyft, Tesla's robo-taxi ambitions) The importance of trust and platform dominance in ride-sharing How autonomous food delivery could boost Uber's revenue Explanation of leap options and “deep-in-the-money” strategies Real-world examples from high-profile investors The reason Uber's stock price could soon reflect its full potentialStay tuned for more Market Mondays as we bring you fresh takes, real numbers, and strategies from the streets to the boardroom.*Don't forget to like, subscribe, and comment with your thoughts or questions below!* #Uber #MarketMondays #Stocks #Investing #AutonomousVehicles #OptionsTrading #LeapOptions #Finance #Rideshare #TechStocks #Waymo #Tesla #FinancialEducation #StockMarket #LongTermInvestingOur Sponsors:* Check out PNC Bank: https://www.pnc.comSupport this podcast at — https://redcircle.com/marketmondays/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

(0:00) The Besties welcome Travis Kalanick and Keith Rabois! (3:02) Travis on Pony.ai / Uber rumors and the state of Cloud Kitchens (18:51) xAI launches Grok 4, learning "The Bitter Lesson" in AI (40:36) How Grok can catch ChatGPT in usage, OpenAI's product excellence (46:27) Perplexity and OpenAI building AI-native browsers and taking on Chrome (58:01) Elon's "America Party": is now the right time for a third party, and could he make an impact in 2026? (1:13:12) SCOTUS backs Trump over federal government RIF plans Follow the Keith: https://x.com/rabois Follow the Travis: https://x.com/travisk Get The Besties All-In Tequila: https://tequila.allin.com Join us at the All-In Summit: https://allin.com/summit Summit scholarship application: http://bit.ly/4kyZqFJ Follow the besties: https://x.com/chamath https://x.com/Jason https://x.com/DavidSacks https://x.com/friedberg Follow on X: https://x.com/theallinpod Follow on Instagram: https://www.instagram.com/theallinpod Follow on TikTok: https://www.tiktok.com/@theallinpod Follow on LinkedIn: https://www.linkedin.com/company/allinpod Intro Music Credit: https://rb.gy/tppkzl https://x.com/yung_spielburg Intro Video Credit: https://x.com/TheZachEffect Referenced in the show: https://www.nytimes.com/2025/06/26/technology/uber-travis-kalanick-self-driving-car-deal.html https://www.youtube.com/watch?v=ZW5fJikPmfM https://grok.com https://www.youtube.com/watch?v=_wTA90BYo30 https://techcrunch.com/2025/01/08/elon-musk-agrees-that-weve-exhausted-ai-training-data https://x.com/ArtificialAnlys/status/1943166841150644622 https://x.com/elonmusk/status/1943192643439337753 http://www.incompleteideas.net/IncIdeas/BitterLesson.html https://x.com/chamath/status/1943177837956968499 https://techcrunch.com/2025/07/09/perplexity-launches-comet-an-ai-powered-web-browser https://x.com/perplexity_ai/status/1942969263305671143 https://x.com/elonmusk/status/1941584569523732930 https://polymarket.com/event/will-elon-register-the-america-party-by https://ropercenter.cornell.edu/presidential-approval/highslows https://news.gallup.com/poll/651278/support-third-political-party-dips.aspx https://www.whitehouse.gov/presidential-actions/2025/02/implementing-the-presidents-department-of-government-efficiency-workforce-optimization-initiative https://www.scotusblog.com/2025/07/supreme-court-allows-trump-administration-to-implement-plans-to-significantly-reduce-the-federal-workforce https://www.afge.org/article/summary-of-afge-lawsuits-against-trump--how-litigation-works https://cei.org/publication/10kc-2025-numbers-of-rules https://www.netflix.com/tudum/articles/american-manhunt-osama-bin-laden-release-date-news

Europe's self-driving car industry has lagged behind the Chinese and American markets. German automaker Volkswagen may remedy that problem next year, when it will debut its robotaxi ride-pool service in the U.S. Plus: Big publishers may have a new way to take on the AI industry's encroaching web scrapers. Patrick Coffee hosts. Sign up for the WSJ's free Technology newsletter. Programming note: Starting this week, Tech News Briefing episodes will be released on Tuesdays and Fridays, and the TNB Tech Minute will be released twice on weekdays, in the morning and afternoon. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Top Five at 5:00 Could Retzlaff be a Viable QB Option? Trouble with Ubers

Mark Thompson dives into some of LA's biggest political stories, starting with Mayor Karen Bass's new interview with Telemundo, where she defends her leadership and hints at legal tensions with the feds. Then, Mark turns his focus to Gavin Newsom's headline-grabbing trip to South Carolina, calling out the California governor's not-so-subtle 2028 presidential ambitions. Later, Mark welcomes in-studio guest Steve Broda, the founder of Truc-Ya — a new app dubbed the “Uber for large haul trips.” Finally, the hour wraps on a delicious note as Mark and Stef Foosh celebrate the return of snack wraps to McDonald's after nearly a decade off the menu.

In this Just The Tip episode, we're taking you on a dreamy, slow-travel day trip from Nice to Monaco, where elegance meets coastal beauty and every step feels cinematic. This guide is packed with tips on timing, transportation, and where to go for the best views, snacks, and surprises—even if you're skipping the casino tables. Kim shares exactly how to spend a day soaking up Monaco's highlights, including:How to get there: Uber vs. trainWatching the Changing of the Guard at the Prince's PalaceStrolling colorful alleys and grabbing arancini at Sorrento RistoranteSnapping stunning photos at Point de vue Port de FontvieilleWalking the F1 Grand Prix trackCooling off inside the Monte Carlo CasinoWandering lush gardens and gazing at mega yachts in Hercules HarborMonaco hotels we recommend:Fairmont Monte Carlo - Perfect location with gorgeous water viewsMonte-Carlo Bay Hotel & Resort - Elegant hotel with 5-star service and gorgeous viewsHotel de Londres - Affordable price very close, one town over in MentonCheck out our curated list South of France Experiences for all the tours and activities we recommend in Monaco and beyond in the French Riviera.Find a great flight deal to Monaco by signing up for Thrifty Traveler Premium and watching the daily flight deals (points & cash) that are emailed directly to you! Use our promo code TS10 to get $10 off your first year subscription.—---------------------------------------Shop: Trip Itineraries ⁠& ⁠Amazon Storefront ⁠Connect: ⁠YouTube⁠, ⁠TikTok⁠, and ⁠Instagram⁠⁠ ⁠and contact us at travelsquadpodcast@gmail.com to submit a question of the week or inquire about guest interviews and advertising. Submit a question of the week or inquire about guest interviews and advertising.

How do you build a higher education brand that feels personal, relevant, and rooted in real-world value? Jermaine Peguese, Owner and Lead Strategist of EJST Marketing, shares how his team taps into authentic storytelling, community conversations, and industry voices to connect with today's learners. From launching content series like Next Pulse at Nexford University to shaping market strategies with startup agility, Jermaine shows how higher ed marketers can think big, take risks and challenge the status quo. Full Episode Details  Jermaine joins host Zontee Hou on this episode of Social Pros to explore how marketing in higher education can be reimagined by leaning into authenticity, community, and social influence. Jermaine and Zontee discuss how today's students aren't just looking for facts, they're also looking for real voices they trust and want to see themselves in the stories being shared. Whether it's through expert-led content like Nexford's Next Pulse series or conversations in online forums, Jermaine shows how the most powerful messages come from relatable, human experiences. He also shares how his time at Uber shaped his fast-moving, test-and-learn mindset, and why marketers should stay open to bold ideas— even late in the quarter. When entering new markets, Jermaine emphasizes the value of doing the groundwork: understanding your audience, and building a smart media mix that puts your message in the right places. It's not about being perfect; it's about being real, being thoughtful, and being ready to take a few smart risks, because that's where breakthrough moments happen. In This Episode: 1:55 -   Disrupting the traditional space of higher ed marketing 6:27 -   Building a unique brand voice in the higher ed space  8:45 - How Jermaine's team has catered to non-traditional learners 11:51 -   How to identify core customers  15:39 - How Jermaine thinks about data collection and customer research as an ongoing practice  18:52 -  Using AI in the traditionally AI-adverse higher ed space, and how AI can help marketers in this moment  23:59 - Tapping into communities, social groups and others influencing prospective students  29:22 - Lessons from Uber, and what higher ed can learn from the startup world 31:48 - Solving problems when moving into a new marketing space 37:16 - Jermaine's advice for aspiring social pros Resources: Connect with Jermaine on LinkedIn Follow EJST Marketing on LinkedIn   Visit SocialPros.com for more insights from your favorite social media marketers.

I'm alive in Bangor, Maine — a sentence that somehow feels like the opening line of a novel. In this episode of the Free Outside Show, I walk you through my chaotic arrival to the start of my Appalachian Trail FKT training camp, including a 1 a.m. walk from the airport (no Ubers in Bangor, apparently) and my deep dive into specificity. I'm testing everything: my exact 7,000-calorie-per-day nutrition, gear kit, FKT pacing strategy, and resupply logistics — all in the hardest section of the trail.I also talk about working on the road, training smart, respecting the difficulty of the White Mountains, and building the blueprint for a successful AT attempt. Plus: some sponsor shoutouts to Garage Grown Gear, CS Instant Coffee, and Janji (yes, I am currently dressed head-to-toe in Janji gear — including the pockets I'll be eating out of for the next 40+ days).Want to support the mission? Check out patreon.com/freeoutside — and until next time, stay elite, my friends.Sound Bites"I just went to Tim Hortons.""I got from Garage Grown Gear.""Life's pretty crazy, you know?"Chapters00:00 Journey to Bangor, Maine03:22 Training for the Appalachian Trail10:27 Preparation and Gear for the TrailSubscribe to Substack: http://freeoutside.substack.comSupport this content on patreon: HTTP://patreon.com/freeoutsideBuy my book "Free Outside" on Amazon: https://amzn.to/39LpoSFEmail me to buy a signed copy of my book, "Free Outside" at jeff@freeoutside.comWatch the movie about setting the record on the Colorado Trail: https://tubitv.com/movies/100019916/free-outsideWebsite: www.Freeoutside.comInstagram: thefreeoutsidefacebook: www.facebook.com/freeoutside

Clarence is naked. Doc (Oc) is jumping into Ubers. Jess the naga-reaper is shedding her skin across rush hour like it's molting season in hell.After the chaos, Clarence reveals he has a brother. But elsewhere, Monday - with a broken heart and blade - wanders into a quiet park. There, memories begin to surface. A spark ignites. Sword ki stirs within him.Then, a face: Patches. He was in the temple. The memory returns, and with it comes another name... Rolo. PLAY THE DUST WORLD RPG NOW:We've released the epic RPG Dust world and we want your help. Dust World PBTA is RPG Empire's sci-fi western game that's simple, fast, and Powered By The Apocalypse. Are you ready? Enter The Gun-Filled Lands Of An Obliterated Civilization. Play as gunslinging anime-inspired heroes on their mission to discover the truth behind the lost civilization and its technology. GET THE GUIDE NOW:https://www.therpgempire.com/shop/p/b2ck9ai8u8d7i6j5xs48oojt742uq2Dust world RPG Podcast is an actual play Role-playing podcast like the Adventure Zone Podcast or Critical Role. The setting is a sci-fi western a few hundred years after a great war burned the earth and a virus called white horse dissolved most organic matter into dust creating the wastelands.Dust World RPG is a Powered By The Apocalypse game. Dust World is a Tabletop Role-Playing game created by Paul Parnell Copywrite 2020. The setting was created by Paul Parnell and Michael Yatskar. The game was written by Paul-Thomas Parnell and Dumaresq de Pencier.OTHER PROJECTS FROM THE RPG EMPIRE:Strangers in the Pines: A Monster Of The Week actually play roleplaying podcast inspired by things like Gravity Falls, Stranger Things, and Fringe. It takes place in a small strange town called Pine Forge nestled in the Blackwood national park in Northeast Oregon, USA, and follows, the exploits of 3 unusual high school students as they try to unravel the mysteries of the Strangers in the Pines.https://www.therpgempire.com/strangers-in-the-pinesCONNECT WITH US:Join our Discord Server to chat with us and talk all things RPGs: https://discord.gg/2jnyGv9Follow and send us DMs on Instagram: @theRPGempireJoin the Empire!

Chris Granger takes over as Oak View Group's CEO as Tim Leiweke steps down after indictment; Uber's partnership with LA28 and Team USA and MLB to add ABS challenge system to next week's All-Star Game.

Today, I'm joined by Laura Conley to unpack why so many moms struggle to lose weight.Laura shares the raw moment that transformed her relationship with food and sparked her mission to help moms lose weight without shame, obsession, or sacrifice.If you've ever found yourself stress-eating cheddar bunnies after bedtime or felt guilty for wanting more than crumbs of time for yourself, this episode will speak to you.You'll learn…- Where mom guilt comes from- How to fill your “pleasure cup” so you don't rely on food for joy- Asking your partner for support so you can prioritize yourself without guilt- How to teach your kids about body image and their relationship with food- What people pleasing has to do with overeatingLaura Conley is the founder of the Yummy Mummy Method (which has successfully helped hundreds of women lose weight for the last time!) and has been lovingly labeled the “Fun Weight Loss Coach” by her clients. Laura helps mamas who have been painfully struggling with diet drama to lose weight for the last time and free themselves from food chatter forever - all from a place of love. She is on a major mission to do this so that her clients can pass down a beautiful legacy to their children and live the life they have always dreamed of. She does this through her unique and proven method that helps her clients through balancing their hunger hormones, rewiring their brains, feeling emotions, providing loving accountability and becoming their own bestie.Laura is the host of the top 1.5% podcast called Lose Weight for the Last Time Podcast and has been featured on the Be Well By Kelly Podcast with Kelly LeVeque, The Earn Your Happy Podcast with Lori Harder and has worked with Brands like Uber, Nike, and Twitter.Laura Conley's Resources:

In this episode of Beyond Limits, Olivia sits down with Rachel Wong—the co-founder of Monday Girl, one of North America's fastest-growing networking platforms for professional women.What started as a Sunday afternoon coffee chat between two strangers turned into a movement with thousands of members across cities like Toronto, New York, San Francisco, and London.Rachel opens up about bootstrapping Monday Girl while working at Uber, what it's really like to build a brand with your co-founder from day one, and why creating space for soft power is the future of women-led networking.She and Liv go deep into what makes a Monday Girl so magnetic, how to protect feminine leadership in a tech bro world, and why access is everything in your 20s and 30s.Key Takeaways:

Sports Geek Rapid Rundown is a daily sports business podcast curated by Sports Geek Reads. We publish it on Sports Geek twice per week. In this episode: Dive into the latest sports business news with updates on Apple's push for F1 broadcasting rights, Uber's Olympic partnership for LA 2028, and the Big 12's international expansion plans. Plus, insights on NIL approval challenges and the Utah Royals' remarkable $100 million valuation, all curated by Sports Geek Reads. Subscribe at https://sportsgeekhq.com/rapidrundown.

Jacob calls in from the back of an Uber in Richmond, VA to talk Creighton basketball beginning their summer workouts, Allan Huss and his involvement, NBA Summer League, and our massive MLB Draft preview.

The all-time high run is what Larry Tentarelli considers the biggest bullish signal for a higher run following investor resilience through tariffs and the Big, Beautiful Bill. Larry has several stocks on his radar, from Uber Technologies (UBER) as a rideshare leader, to GE Vernova's (GEV) role in powering A.I. He also notes CrowdStrike's (CRWD) importance in cybersecurity and Snowflake (SNOW) as a competitive alternate to Palantir (PLTR).======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-...Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-...Watch on Sling - https://watch.sling.com/1/asset/19192...Watch on Vizio - https://www.vizio.com/en/watchfreeplu...Watch on DistroTV - https://www.distro.tv/live/schwab-net...Follow us on X – / schwabnetwork Follow us on Facebook – / schwabnetwork Follow us on LinkedIn - / schwab-network About Schwab Network - https://schwabnetwork.com/about

Dan Deming joins today's Big 3 and turns to three stocks that he believes investors should keep on their radar as the market "broadens." He talks about the potential for Broadcom (AVGO) to continue its rally after its tremendous run higher, Eli Lilly's (LLY) role in the "vanity trade," and Uber Technologies (UBER) finding its "niche" as autonomous driving evolves. Rick Ducat gives investors insight into the bearish and bullish indicators he found in the charts.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-...Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-...Watch on Sling - https://watch.sling.com/1/asset/19192...Watch on Vizio - https://www.vizio.com/en/watchfreeplu...Watch on DistroTV - https://www.distro.tv/live/schwab-net...Follow us on X – / schwabnetwork Follow us on Facebook – / schwabnetwork Follow us on LinkedIn - / schwab-network About Schwab Network - https://schwabnetwork.com/about

- Investors Like the Potential of Robotaxis - BMW Just Eked Out Q2 Gain - Japanese Automakers Cut Prices of Exported Vehicles - Ford and Stellantis Squeeze Their Suppliers - Hyundai Reveals Performance Electric Sedan - EVs Hold Value Better in China - Mazda CX-5 Getting 1st Hybrid - Maserati Gives Its Supercar a New Name

Dr. Paul Hanona and Dr. Arturo Loaiza-Bonilla discuss how to safely and smartly integrate AI into the clinical workflow and tap its potential to improve patient-centered care, drug development, and access to clinical trials. TRANSCRIPT Dr. Paul Hanona: Hello, I'm Dr. Paul Hanona, your guest host of the ASCO Daily News Podcast today. I am a medical oncologist as well as a content creator @DoctorDiscover, and I'm delighted to be joined today by Dr. Arturo Loaiza-Bonilla, the chief of hematology and oncology at St. Luke's University Health Network. Dr. Bonilla is also the co-founder and chief medical officer at Massive Bio, an AI-driven platform that matches patients with clinical trials and novel therapies. Dr. Loaiza-Bonilla will share his unique perspective on the potential of artificial intelligence to advance precision oncology, especially through clinical trials and research, and other key advancements in AI that are transforming the oncology field. Our full disclosures are available in the transcript of the episode. Dr. Bonilla, it's great to be speaking with you today. Thanks for being here. Dr. Arturo Loaiza-Bonilla: Oh, thank you so much, Dr. Hanona. Paul, it's always great to have a conversation. Looking forward to a great one today. Dr. Paul Hanona: Absolutely. Let's just jump right into it. Let's talk about the way that we see AI being embedded in our clinical workflow as oncologists. What are some practical ways to use AI? Dr. Arturo Loaiza-Bonilla: To me, responsible AI integration in oncology is one of those that's focused on one principle to me, which is clinical purpose is first, instead of the algorithm or whatever technology we're going to be using. If we look at the best models in the world, they're really irrelevant unless we really solve a real day-to-day challenge, either when we're talking to patients in the clinic or in the infusion chair or making decision support. Currently, what I'm doing the most is focusing on solutions that are saving us time to be more productive and spend more time with our patients. So, for example, we're using ambient AI for appropriate documentation in real time with our patients. We're leveraging certain tools to assess for potential admission or readmission of patients who have certain conditions as well. And it's all about combining the listening of physicians like ourselves who are end users, those who create those algorithms, data scientists, and patient advocates, and even regulators, before they even write any single line of code. I felt that on my own, you know, entrepreneurial aspects, but I think it's an ethos that we should all follow. And I think that AI shouldn't be just bolted on later. We always have to look at workflows and try to look, for example, at clinical trial matching, which is something I'm very passionate about. We need to make sure that first, it's easier to access for patients, that oncologists like myself can go into the interface and be able to pull the data in real time when you really need it, and you don't get all this fatigue alerts. To me, that's the responsible way of doing so. Those are like the opportunities, right? So, the challenge is how we can make this happen in a meaningful way – we're just not reacting to like a black box suggestion or something that we have no idea why it came up to be. So, in terms of success – and I can tell you probably two stories of things that we know we're seeing successful – we all work closely with radiation oncologists, right? So, there are now these tools, for example, of automated contouring in radiation oncology, and some of these solutions were brought up in different meetings, including the last ASCO meeting. But overall, we know that transformer-based segmentation tools; transformer is just the specific architecture of the machine learning algorithm that has been able to dramatically reduce the time for colleagues to spend allotting targets for radiation oncology. So, comparing the target versus the normal tissue, which sometimes it takes many hours, now we can optimize things over 60%, sometimes even in minutes. So, this is not just responsible, but it's also an efficiency win, it's a precision win, and we're using it to adapt even mid-course in response to tumor shrinkage. Another success that I think is relevant is, for example, on the clinical trial matching side. We've been working on that and, you know, I don't want to preach to the choir here, but having the ability for us to structure data in real time using these tools, being able to extract information on biomarkers, and then show that multi-agentic AI is superior to what we call zero-shot or just throwing it into ChatGPT or any other algorithm, but using the same tools but just fine-tuned to the point that we can be very efficient and actually reliable to the level of almost like a research coordinator, is not just theory. Now, it can change lives because we can get patients enrolled in clinical trials and be activated in different places wherever the patient may be. I know it's like a long answer on that, but, you know, as we talk about responsible AI, that's important. And in terms of what keeps me up at night on this: data drift and biases, right? So, imaging protocols, all these things change, the lab switch between different vendors, or a patient has issues with new emerging data points. And health systems serve vastly different populations. So, if our models are trained in one context and deployed in another, then the output can be really inaccurate. So, the idea is to become a collaborative approach where we can use federated learning and patient-centricity so we can be much more efficient in developing those models that account for all the populations, and any retraining that is used based on data can be diverse enough that it represents all of us and we can be treated in a very good, appropriate way. So, if a clinician doesn't understand why a recommendation is made, as you probably know, you probably don't trust it, and we shouldn't expect them to. So, I think this is the next wave of the future. We need to make sure that we account for all those things. Dr. Paul Hanona: Absolutely. And even the part about the clinical trials, I want to dive a little bit more into in a few questions. I just kind of wanted to make a quick comment. Like you said, some of the prevalent things that I see are the ambient scribes. It seems like that's really taken off in the last year, and it seems like it's improving at a pretty dramatic speed as well. I wonder how quickly that'll get adopted by the majority of physicians or practitioners in general throughout the country. And you also mentioned things with AI tools regarding helping regulators move things quicker, even the radiation oncologist, helping them in their workflow with contouring and what else they might have to do. And again, the clinical trials thing will be quite interesting to get into. The first question I had subsequent to that is just more so when you have large datasets. And this pertains to two things: the paper that you published recently regarding different ways to use AI in the space of oncology referred to drug development, the way that we look at how we design drugs, specifically anticancer drugs, is pretty cumbersome. The steps that you have to take to design something, to make sure that one chemical will fit into the right chemical or the structure of the molecule, that takes a lot of time to tinker with. What are your thoughts on AI tools to help accelerate drug development? Dr. Arturo Loaiza-Bonilla: Yes, that's the Holy Grail and something that I feel we should dedicate as much time and effort as possible because it relies on multimodality. It cannot be solved by just looking at patient histories. It cannot be solved by just looking at the tissue alone. It's combining all these different datasets and being able to understand the microenvironment, the patient condition and prior treatments, and how dynamic changes that we do through interventions and also exposome – the things that happen outside of the patient's own control – can be leveraged to determine like what's the best next step in terms of drugs. So, the ones that we heard the news the most is, for example, the Nobel Prize-winning [for Chemistry awarded to Demis Hassabis and John Jumper for] AlphaFold, an AI system that predicts protein structures right? So, we solved this very interesting concept of protein folding where, in the past, it would take the history of the known universe, basically – what's called the Levinthal's paradox – to be able to just predict on amino acid structure alone or the sequence alone, the way that three-dimensionally the proteins will fold. So, with that problem being solved and the Nobel Prize being won, the next step is, “Okay, now we know how this protein is there and just by sequence, how can we really understand any new drug that can be used as a candidate and leverage all the data that has been done for many years of testing against a specific protein or a specific gene or knockouts and what not?” So, this is the future of oncology and where we're probably seeing a lot of investments on that. The key challenge here is mostly working on the side of not just looking at pathology, but leveraging this digital pathology with whole slide imaging and identifying the microenvironment of that specific tissue. There's a number of efforts currently being done. One isn't just H&E, like hematoxylin and eosin, slides alone, but with whole imaging, now we can use expression profiles, spatial transcriptomics, and gene whole exome sequencing in the same space and use this transformer technology in a multimodality approach that we know already the slide or the pathology, but can we use that to understand, like, if I knock out this gene, how is the microenvironment going to change to see if an immunotherapy may work better, right? If we can make a microenvironment more reactive towards a cytotoxic T cell profile, for example. So, that is the way where we're really seeing the field moving forward, using multimodality for drug discovery. So, the FDA now seems to be very eager to support those initiatives, so that's of course welcome. And now the key thing is the investment to do this in a meaningful way so we can see those candidates that we're seeing from different companies now being leveraged for rare disease, for things that are going to be almost impossible to collect enough data, and make it efficient by using these algorithms that sometimes, just with multiple masking – basically, what they do is they mask all the features and force the algorithm to find solutions based on the specific inputs or prompts we're doing. So, I'm very excited about that, and I think we're going to be seeing that in the future. Dr. Paul Hanona: So, essentially, in a nutshell, we're saying we have the cancer, which is maybe a dandelion in a field of grass, and we want to see the grass that's surrounding the dandelion, which is the pathology slides. The problem is, to the human eye, it's almost impossible to look at every single piece of grass that's surrounding the dandelion. And so, with tools like AI, we can greatly accelerate our study of the microenvironment or the grass that's surrounding the dandelion and better tailor therapy, come up with therapy. Otherwise, like you said, to truly generate a drug, this would take years and years. We just don't have the throughput to get to answers like that unless we have something like AI to help us. Dr. Arturo Loaiza-Bonilla: Correct. Dr. Paul Hanona: And then, clinical trials. Now, this is an interesting conversation because if you ever look up our national guidelines as oncologists, there's always a mention of, if treatment fails, consider clinical trials. Or in the really aggressive cancers, sometimes you might just start out with clinical trials. You don't even give the standard first-line therapy because of how ineffective it is. There are a few issues with clinical trials that people might not be aware of, but the fact that the majority of patients who should be on clinical trials are never given the chance to be on clinical trials, whether that's because of proximity, right, they might live somewhere that's far from the institution, or for whatever reason, they don't qualify for the clinical trial, they don't meet the strict inclusion criteria.  But a reason you mentioned early on is that it's simply impossible for someone to be aware of every single clinical trial that's out there. And then even if you are aware of those clinical trials, to actually find the sites and put in the time could take hours. And so, how is AI going to revolutionize that? Because in my mind, it's not that we're inventing a new tool. Clinical trials have always been available. We just can't access them. So, if we have a tool that helps with access, wouldn't that be huge? Dr. Arturo Loaiza-Bonilla: Correct. And that has been one of my passions. And for those who know me and follow me and we've spoke about it in different settings, that's something that I think we can solve. This other paradox, which is the clinical trial enrollment paradox, right? We have tens of thousands of clinical trials available with millions of patients eager to learn about trials, but we don't enroll enough and many trials close to accrual because of lack of enrollment. It is completely paradoxical and it's because of that misalignment because patients don't know where to go for trials and sites don't know what patients they can help because they haven't reached their doors yet. So, the solution has to be patient-centric, right? We have to put the patient at the center of the equation. And that was precisely what we had been discussing during the ASCO meeting. There was an ASCO Education Session where we talked about digital prescreening hubs, where we, in a patient-centric manner, the same way we look for Uber, Instacart, any solution that you may think of that you want something that can be leveraged in real time, we can use these real-world data streams from the patient directly, from hospitals, from pathology labs, from genomics companies, to continuously screen patients who can match to the inclusion/exclusion criteria of unique trials. So, when the patient walks into the clinic, the system already knows if there's a trial and alerts the site proactively. The patient can actually also do decentralization. So, there's a number of decentralized clinical trial solutions that are using what I call the “click and mortar” approach, which is basically the patient is checking digitally and then goes to the site to activate. We can also have the click and mortar in the bidirectional way where the patient is engaged in person and then you give the solution like the ones that are being offered on things that we're doing at Massive Bio and beyond, which is having the patient to access all that information and then they make decisions and enroll when the time is right.  As I mentioned earlier, there is this concept drift where clinical trials open and close, the patient line of therapy changes, new approvals come in and out, and sites may not be available at a given time but may be later. So, having that real-time alerts using tools that are able already to extract data from summarization that we already have in different settings and doing this natural language ingestion, we can not only solve this issue with manual chart review, which is extremely cumbersome and takes forever and takes to a lot of one-time assessments with very high screen failures, to a real-time dynamic approach where the patient, as they get closer to that eligibility criteria, they get engaged. And those tools can be built to activate trials, audit trials, and make them better and accessible to patients. And something that we know is, for example, 91%-plus of Americans live close to either a pharmacy or an imaging center. So, imagine that we can potentially activate certain of those trials in those locations. So, there's a number of pharmacies, special pharmacies, Walgreens, and sometimes CVS trying to do some of those efforts. So, I think the sky's the limit in terms of us working together. And we've been talking with corporate groups, they're all interested in those efforts as well, to getting patients digitally enabled and then activate the same way we activate the NCTN network of the corporate groups, that are almost just-in-time. You can activate a trial the patient is eligible for and we get all these breakthroughs from the NIH and NCI, just activate it in my site within a week or so, as long as we have the understanding of the protocol. So, using clinical trial matching in a digitally enabled way and then activate in that same fashion, but not only for NCTN studies, but all the studies that we have available will be the key of the future through those prescreening hubs. So, I think now we're at this very important time where collaboration is the important part and having this silo-breaking approach with interoperability where we can leverage data from any data source and from any electronic medical records and whatnot is going to be essential for us to move forward because now we have the tools to do so with our phones, with our interests, and with the multiple clinical trials that are coming into the pipelines. Dr. Paul Hanona: I just want to point out that the way you described the process involves several variables that practitioners often don't think about. We don't realize the 15 steps that are happening in the background. But just as a clarifier, how much time is it taking now to get one patient enrolled on a clinical trial? Is it on the order of maybe 5 to 10 hours for one patient by the time the manual chart review happens, by the time the matching happens, the calls go out, the sign-up, all this? And how much time do you think a tool that could match those trials quicker and get you enrolled quicker could save? Would it be maybe an hour instead of 15 hours? What's your thought process on that? Dr. Arturo Loaiza-Bonilla: Yeah, exactly. So one is the matching, the other one is the enrollment, which, as you mentioned, is very important. So, it can take, from, as you said, probably between 4 days to sometimes 30 days. Sometimes that's how long it takes for all the things to be parsed out in terms of logistics and things that could be done now agentically. So, we can use agents to solve those different steps that may take multiple individuals. We can just do it as a supply chain approach where all those different steps can be done by a single agent in a simultaneous fashion and then we can get things much faster. With an AI-based solution using these frontier models and multi-agentic AI – and we presented some of this data in ASCO as well – you can do 5,000 patients in an hour, right? So, just enrolling is going to be between an hour and maximum enrollment, it could be 7 days for those 5,000 patients if it was done at scale in a multi-level approach where we have all the trials available. Dr. Paul Hanona: No, definitely a very exciting aspect of our future as oncologists. It's one thing to have really neat, novel mechanisms of treatment, but what good is it if we can't actually get it to people who need it? I'm very much looking for the future of that.  One of the last questions I want to ask you is another prevalent way that people use AI is just simply looking up questions, right? So, traditionally, the workflow for oncologists is maybe going on national guidelines and looking up the stage of the cancer and seeing what treatments are available and then referencing the papers and looking at who was included, who wasn't included, the side effects to be aware of, and sort of coming up with a decision as to how to treat a cancer patient. But now, just in the last few years, we've had several tools become available that make getting questions easier, make getting answers easier, whether that's something like OpenAI's tools or Perplexity or Doximity or OpenEvidence or even ASCO has a Guidelines Assistant as well that is drawing from their own guidelines as to how to treat different cancers. Do you see these replacing traditional sources? Do you see them saving us a lot more time so that we can be more productive in clinic? What do you think is the role that they're going to play with patient care? Dr. Arturo Loaiza-Bonilla: Such a relevant question, particularly at this time, because these AI-enabled query tools, they're coming left and right and becoming increasingly common in our daily workflows and things that we're doing. So, traditionally, when we go and we look for national guidelines, we try to understand the context ourselves and then we make treatment decisions accordingly. But that is a lot of a process that now AI is helping us to solve. So, at face value, it seems like an efficiency win, but in many cases, I personally evaluate platforms as the chief of hem/onc at St. Luke's and also having led the digital engagement things through Massive Bio and trying to put things together, I can tell you this: not all tools are created equal. In cancer care, each data point can mean the difference between cure and progression, so we cannot really take a lot of shortcuts in this case or have unverified output. So, the tools are helpful, but it has to be grounded in truth, in trusted data sources, and they need to be continuously updated with, like, ASCO and NCCN and others. So, the reason why the ASCO Guidelines Assistant, for instance, works is because it builds on all these recommendations, is assessed by end users like ourselves. So, that kind of verification is critical, right? We're entering a phase where even the source material may be AI-generated. So, the role of human expert validation is really actually more important, not less important. You know, generalist LLMs, even when fine-tuned, they may not be enough. You can pull a few API calls from PubMed, etc., but what we need now is specialized, context-aware, agentic tools that can interpret multimodal and real-time clinical inputs. So, something that we are continuing to check on and very relevant to have entities and bodies like ASCO looking into this so they can help us to be really efficient and really help our patients. Dr. Paul Hanona: Dr. Bonilla, what do you want to leave the listener with in terms of the future direction of AI, things that we should be cautious about, and things that we should be optimistic about? Dr. Arturo Loaiza-Bonilla: Looking 5 years ahead, I think there's enormous promise. As you know, I'm an AI enthusiast, but always, there's a few priorities that I think – 3 of them, I think – we need to tackle head-on. First is algorithmic equity. So, most AI tools today are trained on data from academic medical centers but not necessarily from community practices or underrepresented populations, particularly when you're looking at radiology, pathology, and what not. So, those blind spots, they need to be filled, and we can eliminate a lot of disparities in cancer care. So, those frameworks to incentivize while keeping the data sharing using federated models and things that we can optimize is key. The second one is the governance on the lifecycle. So, you know, AI is not really static. So, unlike a drug that is approved and it just, you know, works always, AI changes. So, we need to make sure that we have tools that are able to retrain and recall when things degrade or models drift. So, we need to use up-to-date AI for clinical practice, so we are going to be in constant revalidation and make it really easy to do. And lastly, the human-AI interface. You know, clinicians don't need more noise or we don't need more black boxes. We need decision support that is clear, that we can interpret, and that is actionable. “Why are you using this? Why did we choose this drug? Why this dose? Why now?” So, all these things are going to help us and that allows us to trace evidence with a single click. So, I always call it back to the Moravec's paradox where we say, you know, evolution gave us so much energy to discern in the sensory-neural and dexterity. That's what we're going to be taking care of patients. We can use AI to really be a force to help us to be better clinicians and not to really replace us. So, if we get this right and we decide for transparency with trust, inclusion, etc., it will never replace any of our work, which is so important, as much as we want, we can actually take care of patients and be personalized, timely, and equitable. So, all those things are what get me excited every single day about these conversations on AI. Dr. Paul Hanona: All great thoughts, Dr. Bonilla. I'm very excited to see how this field evolves. I'm excited to see how oncologists really come to this field. I think with technology, there's always a bit of a lag in adopting it, but I think if we jump on board and grow with it, we can do amazing things for the field of oncology in general. Thank you for the advancements that you've made in your own career in the field of AI and oncology and just ultimately with the hopeful outcomes of improving patient care, especially cancer patients. Dr. Arturo Loaiza-Bonilla: Thank you so much, Dr. Hanona. Dr. Paul Hanona: Thanks to our listeners for your time today. If you value the insights that you hear on ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. More on today's speakers:    Dr. Arturo Loaiza-Bonilla @DrBonillaOnc Dr. Paul Hanona @DoctorDiscover on YouTube Follow ASCO on social media:      @ASCO on Twitter      ASCO on Facebook      ASCO on LinkedIn    ASCO on BlueSky Disclosures: Paul Hanona: No relationships to disclose. Dr. Arturo-Loaiza-Bonilla: Leadership: Massive Bio Stock & Other Ownership Interests: Massive Bio Consulting or Advisory Role: Massive Bio, Bayer, PSI, BrightInsight, CardinalHealth, Pfizer, AstraZeneca, Medscape Speakers' Bureau: Guardant Health, Ipsen, AstraZeneca/Daiichi Sankyo, Natera

London's most popular restaurant, Dishoom, has a wild growth hack… Roll the dice, get a free meal.Amazon Prime Day is now Prime Week… but it's really a fake deal mind game.One biz is saving flood victims in Texas: H-E-B… the $47B grocery chain bigger than Uber.Plus, Ozzy Osborne is selling his DNA in Liquid Death water cans… and it's a new celeb trend.$AMZN $WMT $SPYWant more business storytelling from us? Check out the latest episode of our new weekly deepdive show: The untold origin story of… Subscribe to The Best Idea Yet: Wondery.fm/TheBestIdeaYetLinks to listen.TBOY Live Show Tickets to Chicago on sale NOW: https://www.axs.com/events/949346/the-best-one-yet-podcast-ticketsAbout Us: The daily pop-biz news show making today's top stories your business. Formerly known as Robinhood Snacks, TBOY Lite is hosted by Jack Crivici-Kramer & Nick Martell.GET ON THE POD: Submit a shoutout or fact: https://tboypod.com/shoutouts NEWSLETTER:https://tboypod.com/newsletter SOCIALS:Instagram: https://www.instagram.com/tboypod TikTok: https://www.tiktok.com/@tboypodYouTube: https://www.youtube.com/@tboypod Anything else: https://tboypod.com/ Our 2nd show… The Best Idea Yet: Wondery.fm/TheBestIdeaYetLinksEpisodes drop weekly.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

At the start of the year, I made seven predictions about how 2025 would unfold. Six months in, it's time to mark my own work. From AI capability breakthroughs to autonomous vehicles, climate extremes to workforce transformation, I examine what I got right, what I missed, and why the 2027-2028 period will be when vertical AI hits the real economy in force.In this episode you'll hear:The AI wall that never came: Ten-million-token models exist, O3 scores 25% on Frontier Math vs GPT-4's 2%, but some models are inconsistent and overthink problemsWhen bots officially out-talk humans: My modeling shows LLMs crossed the threshold of producing more text than humans sometime this summerThe Waymo vs Uber SF battle: They've beaten Lyft and expanded to New York, but Tesla's Austin robo-taxi fleet changes the competitive landscapeClimate and energy predictions that were "too easy": Record climate extremes, 30% solar growth, and Indonesia's stunning EV jump from 20% to 80% in two yearsWhat I completely missed: The AI capex boom, humanoid robots at Figure/BMW/Amazon, and workforce impact with CEOs reporting 20-50% AI assistanceWhy getting too many predictions right is a problem: I reflect on whether scoring too well means I didn't push boundaries enough in my forecastingThe 2027-2028 turbulence ahead: Why four-year-old AI startups challenging incumbents while early adopters reap deep organizational benefits will create economic turbulenceOur new showThis was originally recorded for “Friday with Azeem Azhar”, a new show that takes place every Friday at 9am PT and 12pm ET. You can tune in through my Substack linked below.The format is experimental and we'd love your feedback, so feel free to comment or email your thoughts to our team at live@exponentialview.co.Azeem's links:Substack: https://www.exponentialview.co/Website: https://www.azeemazhar.com/LinkedIn: https://www.linkedin.com/in/azhar?originalSubdomain=ukTwitter/X: https://x.com/azeemTimestamps:(00:00) Grading my predictions from January 2025(01:23) #1: No AI Wall(03:59) #2: Warp-speed deployment(05:16) #3: Bots out-talk humans(06:24) #4: Waymo overtakes Uber in SF(08:31) #5: Climate extremes intensify(09:09) #6: Solar keeps breaking records(10:06) #7: EVs shift up a gear(11:12) The problem with predicting too accurately(12:01) What I missed(12:14) The CapEx boom around AI(13:56) The rise of humanoid robots(14:36) AI's impact on the workforce(18:40) Looking ahead(18:48) Infrastructure first, apps next(19:52) 2027/2028 will be a "period of fireworks"(21:39) When we'll find out if AI is a bubble(23:02) A question for the futureProduction:Production by supermix.io and EPIIPLUS1 Ltd

Jim and Them Wedding Bells: We get a call from Kody that is legit calling from his Wedding Night, a NEW milestone! Quiet Place Monsters: Jim faces an emotional crisis as he imagines the Quiet Place aliens arriving and having to sacrifice his Yorkie, Caesar. Palette Cleansers: We got some nice calls, we check in on Dank Demoss and the dough covered in flies. THE BEAR!, FUCK YOU, WATCH THIS!, DEFTONES!, MY OWN SUMMER (SHOVE IT)!, 871 PART 2!, BABY DICK!, JUNETEENTH!, RUNNING THE BOARDS!, CLIPS!, TAKE A PISS!, LUSCIOUS LIPS!, KODY!, SEVEJAX!, CALL IN!, WEDDING DAY!, RELATIONSHIP!, 2013!, PAUSE!, AYO!, CEREMONY TYPE!, ELOPED!, FAMILY GET TOGETHER!, CANADA!, WEDDING SONG!, THE KILLERS!, WEDDING TOAST!, 9/11 BOYS!, JAKE!, BRIAN!, KODY AND BRITNEY!, CHARLIE!, BURGER WOLF!, P-52S!, PATRICK!, CHARLIE!, WASTE OF TIME!, FRIENDSHIP ARC!, SHOW BIBLE!, FORBIDDEN FRUIT!, WORK HUSBAND!, MAX MURDER!, EMOTIONAL!, QUIET PLACE!, ALIENS!, YORKIE!, STREAMATHON!, RAP OFF!, EROK!, EFFORT!, EMBRYO WATER!, THE WATER IS FINE!, WARM!, WOMB!, GEN X PODCAST!, COREY GOFUNDME!, VIOLENT J!, ICP!, ANDY LOWE!, SYDNEY!, DANK DEMOSS!, FAT!, SUED LYFT!, UBER!, PLAN B!, NUTTING IN ME!, KFC!, POPEYES!, SIT ON A FIRECRACKER!, FIREWORKS!, TERRY!, FLIES!, BEES!, DOUGH!, JUICE!, WHEELCHAIR!, JAUNDICE!, TIKTOK WEIRDOS!, IN ON THE BIT!, JESUS LOVES YOU!, FUCKED UP!  You can find the videos from this episode at our Discord RIGHT HERE!

Sam's mom, Ms. Judy, was a flower girl at a wedding.How you can view your Uber rating as a rider.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Mandy is miserable about being stuck overnight at the airport, house parties that run out of booze, and Uber drivers who treat the ride like a TED Talk.In today's episode, we dive into a myriad of topics from energy drinks and the habit of always holding a drink, to the chaos of college party habits. The host reminisces about house parties and the quirky strategy of hiding beers behind the ranch dressing. We explore the art of engagement on social media and the importance of audience interaction, especially with hilarious segments like 'Weekly Wieners' and 'Misery Loves Company.' Personal anecdotes about travel mishaps, particularly confusing airports, bring a humorous yet real-life touch to the episode. Mandy also shares frustrations of working in the comedy industry and the existential crises that come along with a busy schedule. Join us for a candid, comedic take on life's everyday nuisances and the ongoing journey to better connect with the audience.

Los peores momentos para pesarte y otros saboteadores que no te dejan bajar de peso / ¿Están desapareciendo los hashtags? / ¿Cómo le hacen los conductores de UBER?

Ben bach life Belle would eat a pie for how much? Someone thought Liam was in Harry Potter Who’s scamming the company Uber? Join the Pod Squad Listen Live on the Nova Player App Follow us on Instagram - TikTok - Facebook - SnapchatSee omnystudio.com/listener for privacy information.

Microsoft says late-night meetings are up 16%. Burnout much? I also talk to an Uber driver almost tricked into trafficking stolen goods. Plus: Trump Org's new phone biz, Bible stories on TikTok, and a smart way to check your internet speed. Learn more about your ad choices. Visit megaphone.fm/adchoices

It's always sunny in Sunnyvale – and hot as f**k after Ricky trashed the aircon! Discover who fought Elvis in Fredericton, why Bubbles wants a lip job, and the dangers of gettin' greasy with 50 Shades Of Grey. Plus: Flex Seal, Doritos, Uber? You're awesome... now pay up!

Comedian Jacob Balshin joins us to talk dirt malls, Mission Impossible , and an Uber dilemma. Follow us: Instagram, Facebook, Bluesky.

Plus: The megabill's no tax on tips provision could bring in a 2.5% pay bump for Uber drivers. And Boldstart Ventures raises a $250 million AI fund. Julie Chang hosts. Programming note: Starting this week, Tech News Briefing episodes will be released on Tuesdays and Fridays, and the TNB Tech Minute will be released twice on weekdays, in the morning and afternoon. Learn more about your ad choices. Visit megaphone.fm/adchoices

Scott Wapner and the Investment Committee debate the continued run in stocks as more street strategists raise their S&P targets.  Plus, the desk share their latest portfolio moves. And later, Uber hits a new record high as Tesla faces pressure, the Committee break down the trade.  Investment Committee Disclosures

Why we could see a 12% correction in stocks by year-end. Elon Musk telling Wedbush's Dan Ives to “shut up.” Ives joins to dig into what's got Musk so fired up. Plus, Bank of America bullish on Uber thanks in part to President Trump's megabill. 

In this episode of Econ 102, we're republishing a conversation between Noah Smith and Derek Thompson. They explore Derek's shift from The Atlantic to Substack and unpack the “abundance agenda” — a vision for revitalizing American politics through better housing, energy, and innovation policy. Their wide-ranging conversation touches on economic reform, trendspotting, and the evolving media landscape. – SPONSORS: NetSuite More than 42,000 businesses have already upgraded to NetSuite by Oracle, the #1 cloud financial system bringing accounting, financial management, inventory, HR, into ONE proven platform. Download the CFO's Guide to AI and Machine learning: ⁠⁠⁠⁠⁠⁠⁠⁠https://netsuite.com/102⁠⁠⁠⁠⁠⁠⁠⁠ Shopify Shopify is the world's leading e-commerce platform, offering a market-leading checkout system Shoppay and exclusive AI apps. Nobody does selling better than Shopify. Get a $1 per month trial at ⁠⁠⁠https://shopify.com/momentofzen⁠⁠⁠. AdQuick The easiest way to book out-of-home ads (like billboards, vehicle wraps, and airport displays) the same way you would order an Uber. Ready to get your brand the attention it deserves? Visit ⁠⁠⁠⁠⁠⁠⁠⁠https://adquick.com/⁠⁠⁠⁠⁠⁠⁠⁠ today to start reaching your customers in the real world. – SEND US YOUR Q's FOR NOAH TO ANSWER ON AIR: Econ102@Turpentine.co – FOLLOW ON X: @noahpinion @DKThomp @eriktorenberg @turpentinemedia – RECOMMENDED IN THIS EPISODE: Derek Thompson Substack: https://www.derekthompson.org/ Abundance: https://www.amazon.com/Abundance-Progress-Takes-Ezra-Klein/dp/1668023482 Paul Krugman: https://paulkrugman.substack.com/ Noahpinion: ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.noahpinion.blog/⁠⁠⁠⁠⁠⁠⁠⁠ ⁠ – TAKEAWAYS: Derek's Move to Substack: Derek left The Atlantic after 17 years to join Substack, driven by "party wanderlust" - seeing the vibrant community of writers like Noah, Matt Yglesias, and others. Art of Trend Spotting: Noah praises Derek's unique ability to identify major trends before others, noting he's "earlier to spot new and important trends than any other blogger or writer." Derek reveals his method involves paying attention to that inner voice asking "what the fuck is that?" about everyday observations - essentially being like "observational humor but not necessarily humorous." Abundance Agenda's Impact: The conversation reveals how the abundance movement has gained significant traction, with Derek noting that partnering with Ezra Klein was strategic since Klein has unique influence within Democratic circles. They discuss "Ezra Klein Derangement Syndrome" - how Klein's prominence makes him both influential and a target. Need to attack MAGA degrowth ideology: Abundance advocates should more aggressively counter Trump's "scarcity mindset" that responds to every shortage with deprivation rather than increased production. Federal housing incentives: Race-to-the-top style funding to reward localities for pro-housing policies.

Being scrappy wasn't just a choice for Gary ‘Vee' Vaynerchuk; it was his only way forward. After years of growing his family's wine business, he was left with nothing of his own. With no money to rent an office or hire employees, Gary leveraged his grit, relationships, and opportunities to launch VaynerMedia. Overcoming the financial, mental, and emotional hurdles of entrepreneurship, he built his company into a multi-million-dollar media empire. In this episode, Gary joins Ilana to reveal the mindset and strategies you need to overcome obstacles and build your own multi-million-dollar business. Gary Vaynerchuk, famously known as GaryVee, is a serial entrepreneur, chairman of VaynerX, CEO of VaynerMedia and VeeFriends, and a six-time New York Times bestselling author. Recognized as one of the most forward-thinking minds in business, culture, and the internet, Gary helps brands stay ahead by spotting trends early. In this episode, Ilana and Gary will discuss: (00:00) Introduction  (01:40) VaynerMedia's Scrappy Beginnings (06:56) Why Businesses Fail Financially (10:01) Navigating Tough Business Days (17:21) The Risk of Over-Transparency in Leadership (19:44) Dealing with Failure and Public Ridicule (22:10) GaryVee's Dream of Owning the New York Jets (26:06) The Role of DNA and Accountability in Success (28:35) Finding Joy in Entrepreneurship (31:02) How to Build a Personal Brand as an Employee (32:30) Empowering Employees with Honest Feedback (34:27) Embracing Change and Executing Relentlessly Gary Vaynerchuk, famously known as GaryVee, is a serial entrepreneur, chairman of VaynerX, CEO of VaynerMedia and VeeFriends, and a six-time New York Times bestselling author. He is a prolific angel investor with early investments in companies like Facebook, Twitter, Tumblr, Venmo, Snapchat, Coinbase, and Uber. Recognized as one of the most forward-thinking minds in business, culture, and the internet, Gary helps brands stay ahead by spotting trends early. Connect with Gary: Gary's Website: garyvaynerchuk.com  Gary's LinkedIn: linkedin.com/in/garyvaynerchuk  Resources Mentioned: Gary's Book, Day Trading Attention: How to Actually Build Brand and Sales in the New Social Media World: https://www.amazon.com/Day-Trading-Attention-Actually-Social/dp/0063317591  GaryVee: From Earning $2 an Hour to Running a $350M Digital Empire: https://podcasts.apple.com/us/podcast/garyvee-from-earning-%242-an-hour-to-running-a/id1701718200?i=1000689595539  Leap Academy: Ready to make the LEAP in your career? There is a NEW way for professionals to Advance Their Careers & Make 5-6 figures of EXTRA INCOME in Record Time. Check out our free training today at leapacademy.com/training

Re-Vamped With Juliet Landau's ultimate trivia contest with YOU! We are down to 8 contenders! Play along to see how much you know! And find out which 4 contenders will be our finalists for this season's Final Battle!! Editor: Patrick Sheffield Composer: Tim Steemson or as Dru calls him, “Little Lamb Timmy.” Artwork: GirlpireThank you:  Council Kerri – Kerri Summers and Haunted Harmony - Harmony Davidson Patreon: https://www.patreon.com/ReVampedwithJulietLandau Send us a textYouTube - https://www.youtube.com/@revampedpod Twitter/X - @julietlandauInstagram - https://www.instagram.com/juliet_landau Facebook - Juliet Landau Official (Page) https://www.facebook.com/julietlandauofficialFacebook - Fans of Juliet Landau (Group) https://www.facebook.com/groups/julietlandau/Email: revampedpod@gmail.com Juliet Landau's directorial feature debut, A Place Among The Dead Trailer: https://vimeo.com/791299045/5b5d98726a A Place Among The Dead Blu-Ray with nearly 5 hours of bonus extras: https://www.amazon.com/gp/product/B0CJJY4MB9/ref=ox_sc_saved_image_4?smid=ATVPDKIKX0DER&psc=1

The Reserve Bank of Australia has thrown one of the great surprises of 2025 by pausing the cash rate at 3.85%. Uber Australia’s advertising business has grown to over $150 million as it doubles down on ads as their latest revenue stream. Aldi has launched a home delivery service in Australia for the first time to get a slice of the growing online grocery industry. _ Download the free app (App Store): http://bit.ly/FluxAppStorel Download the free app (Google Play): http://bit.ly/FluxappGooglePlay Daily newsletter: https://bit.ly/fluxnewsletter Flux on Instagram: http://bit.ly/fluxinsta Flux on TikTok: https://www.tiktok.com/@flux.finance —- The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.See omnystudio.com/listener for privacy information.

Increased ridesharing using robotaxis could bring down traffic levels, says Ivan Feinseth. He believes a car is an under-used asset by sitting around all day, and says an autonomous vehicle could provide more value for consumers by picking up packages and passengers. Ivan says it is the catalyst behind future valuations of both Uber (UBER) and Tesla (TSLA). In self-driving technology space, he likes Mobileye (MBLY) as another weigh to play the autonomous tech trend. Later, Tom White provides a pair of example options trades for UBER.======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-...Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-...Watch on Sling - https://watch.sling.com/1/asset/19192...Watch on Vizio - https://www.vizio.com/en/watchfreeplu...Watch on DistroTV - https://www.distro.tv/live/schwab-net...Follow us on X – / schwabnetwork Follow us on Facebook – / schwabnetwork Follow us on LinkedIn - / schwab-network About Schwab Network - https://schwabnetwork.com/about

Matt Tuttle says there's no comparison between Uber (UBER) and Lyft (LYFT). He thinks Uber is a long-term hold and something to own for 5-years or more. Matt sees the opposite for Lyft, and believes they will be the "Burger King to McDonalds" when stacked against ridesharing comparison. In the autonomous driving space, Matt says "Tesla, I'll believe it when I see it" and says Alphabet's (GOOGL) Waymo is a name to watch.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – / schwabnetwork Follow us on Facebook – / schwabnetwork Follow us on LinkedIn - / schwab-network About Schwab Network - https://schwabnetwork.com/about

Join hosts Ben Rogers, Jeff “Skin” Wade, Kevin “KT” Turner, and Krystina Ray as they dive into a wildly entertaining mix of personal misadventures, community causes, and cultural commentary. From Ben's luxury car oil change debacle (spoiler: it took an hour and left parts behind) to a dangerously flirtatious Uber ride that nearly ended in disaster, this episode is packed with unforgettable moments.

Multi-million dollar rideshare company Uber took it's fight over drivers employment rights to the Supreme court today. The Court is deciding whether it's drivers should be considered employees. This could give the drivers benefits such as leave entitlements, minimum wage and holiday pay. Bill Hickman reports.

Ever caught yourself nodding politely while your Uber driver shares their life story at 3 AM? Or perhaps you've been that driver, watching a clearly intoxicated passenger try to maintain a conversation? This episode dives headfirst into the bizarre social ecosystem of rideshare culture from both sides of the app.Between announcing a packed summer tour schedule (come see me in Seattle, Portland, Oklahoma City, Philadelphia, and my Canadian debut in Edmonton!), I'm unpacking the strange intimacy that forms in the backseat of a stranger's car. From crying in an Uber only to have the driver suggest that "tipping makes her feel better" to pretending to be asleep while a driver monologues about their time in Afghanistan – these fleeting connections reveal so much about how we navigate modern life.The episode takes some philosophical detours too, like imagining reincarnation as a Chipotle-style ordering system where you select your next life experience: "White guy, comic, COVID, poor... with a side of Ubers for the table." It's absurd, yes, but also a telling reflection on the conveniences we've built around ourselves. Between hemorrhoids and luxury gas stations selling $700 artwork, are we really living our best lives?What emerges is a surprising yearning for simplicity – a dream of owning a van with just enough space for a dirt bike, learning to do wheelies, and reconnecting with something tangible in a world increasingly mediated through screens and apps. Whether building trampolines with friends' kids or spotting baby birds learning to fly, there's something deeply satisfying about experiences that don't require a five-star rating afterward.Check out my tour dates and come see me live! And if you notice a gap in my schedule and think I should perform in your city, slide into my DMs – I need to fund this dirt bike dream somehow!

Could a shifting tariff deadline create a further divide between the president and the Fed Chair? And delay what Trump says is a must: rate cuts. Goldman Sachs Vice Chair and former Dallas Fed President Robert Kaplan weighs in. Plus, Boeing reports June orders and deliveries. Then with Uber sitting at an all-time high, how new legislation in Washington could provide a further boost for companies employing gig workers. All that on Money Movers.

MELBOURNE TEST SHOW TICKETS BRAIN ROT TOUR⁠⁠⁠⁠⁠⁠ ALL TICKETS!!! NRL Hall of Famer Cameron Smith talks Origin. Harry runs through the worst situations to have a beer in. AFL: What "SHOULD" Carlton do this week? Carlton NUFFY Snapper is MULTIPLYING! F1: Carnage at Silverstone Did Ryan "Fitzy" Fitzgerald rig a reverse raffle? ⁠⁠⁠⁠HATS HAVE BEEN RESTOCKED - NEW BEERS HAT⁠⁠⁠⁠⁠⁠

Note: Microsoft and the Xbox brand remain subjects of the BDS (Boycott, Divestment, Sanctions) movement for their complicity in the ongoing apartheid and genocide of Palestine. In the interest of journalism we've chosen to cover Microsoft's recent layoffs but encourage you to visit https://www.bdsmovement.net/microsoft for more information.In the wake of an 80 billion dollar investment in AI and the layoff of over 9000 workers, Microsoft ain't lookin' so hot. What does this mean for the rest of the video game industry? Special guest Giovanni Colantonio joins Eric and Nadia to precisely that!Tune in to live recordings of the show every Saturday morning at https://www.twitch.tv/bloodgodpod, subscribe for bonus episodes and discord access at https://www.patreon.com/bloodgodpod and celebrate our 10th Anniversary with new merch at https://shop.bloodgodpod.com Also in this episode: The starfish part of Animorphs Who tanks the Uber driver? Persona 5: The Phantom X's Subway Slammer Summer Games Done Quick Battle Train Rematch Umamusume Timestamps: 6:56 - Main Topic - What Is Happening At Xbox? 1:02:16 - Random Encounters 1:04:00 - The Tavern 1:20:32 - Nadia's Nostalgia Nook Music Used in this Episode: Entry of the Gladiators - [Julius Fucik] Do Your Best - [Breath of Fire III] Pub - [Lunar Knights] A Curious Tale - [Secret of Mana] Palma - [Phantasy Star] Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Harry speaks with Will Coleman, CEO and Co-Founder of Alto, an innovative rideshare and delivery service emphasizing safety, hospitality, and consistency. Will discusses Alto's operations in multiple U.S. cities, their unique business model involving employed drivers and owned vehicles, and their strategic focus on fleet management as a foundation for electric and autonomous mobility. Most importantly, the conversation delves into Alto's newest partnership with Uber, the complexities of fleet management, and the differentiation factors contributing to their success, such as lower insurance costs and high service quality. Will also touches on the benefits and challenges of scaling, and shares insights on the future of autonomous vehicles in the rideshare industry. 00:00 - Introduction to Will Coleman and Alto 01:09 - Will's alternate bio and podcast introduction 02:57 - Alto's unique business model 04:06 - Challenges of fleet management 08:54 - Partnership with Uber 16:18 - Benefits of Alto's model for Uber 21:56 - Unique experience in the rideshare industry 23:30 - Challenges and solutions in fleet management 27:14 - The Alto Fleet and electrification 29:25 - Potential Downsides of the Partnership 34:00 - Alto's Place in the Autonomous Vehicle Market 38:25 - Alto's reaction to the Waymo Business 40:46 - Future Plans and Closing Remarks Alto: https://ridealto.com Will Coleman's LinkedIn: https://www.linkedin.com/in/will-coleman RSG179: Redefining Rideshare with Alto RSG203: An Update on Alto Harry's Newsletter: The Driverless Digest

Two-time Emmy and three-time NAACP Image Award-winning television Executive Producer Rushion McDonald interviewed Suli Salaam. The founder of Paint Your Heaven, on Money Making Conversations Masterclass. Here’s a breakdown of the key topics, highlights, and an about section: Key Themes & Highlights Origins of Paint Your Heaven Salaam explains the inspiration behind the company name, emphasizing the power of vision and positive thinking. He shares how the phrase Paint Your Heaven motivated him at 22 years old to pursue entrepreneurship. Full-Stack Development Expertise Salaam discusses his skills as a full-stack developer, differentiating his work from basic web design. He explains the importance of front-end and back-end development, particularly in creating complex applications like Uber. Challenges & Representation in Tech He highlights the lack of Black full-stack developers and attributes it to self-belief and limited exposure. He shares his personal journey growing up in a challenging neighborhood and how his mother and a supportive teacher encouraged him. AI & Software Innovation Salaam discusses his company’s use of AI and APIs to enhance software development. He reveals a project aimed at simplifying audio production, allowing users to clean up sound with one-click technology. Entrepreneurial Advice & Community Impact He encourages young people to embrace change and pursue careers in programming and AI. His company aims to serve businesses worldwide while also promoting positive thinking in inner-city communities. About Suli Salaam & Paint Your Heaven Suli Salaam is a full-stack developer and entrepreneur based in Kansas City. His company, Paint Your Heaven, specializes in web, app, and software design and development. The company combines technical expertise with creative design, making it a valuable resource for businesses looking to scale. Beyond business, Salaam is passionate about mentoring young people, promoting positive thinking, and helping communities embrace technology. #BEST #STRAW #SHMS Steve Harvey Morning Show Online: http://www.steveharveyfm.com/See omnystudio.com/listener for privacy information.

We would love to hear your feedback!Returning from a Nashville meetup, the team shares wild stories of plastic horse racing, bar games, and questionable Uber experiences, while diving into significant developments in the gig economy.News Links from Ep 258• Nashville meetup featured a plastic horse racing game, bar gambling, and friendly socializing• Jason reaps profits from the weekend games while Faith organizes an entertaining scavenger hunt• Several Uber drivers encountered during the trip had dirty cars, no AC, or falsely claimed to be deaf• Jason recounts a $175 Traverse City run that required negotiation with Curri• New York Taxi Commission now requires rideshare companies to give 72 hours' notice before driver lockouts• An impostor Uber driver in Florida convinced a passenger to switch seats before being caught by police• Uber Eats customer service quality has drastically declined since the platform's early days• Atlanta becomes the fourth city to implement robot deliveries for Uber Eats• Direct cash deals between riders and drivers pose significant insurance risks despite financial benefits• A DoorDash driver refuses to deliver Plan B medication, raising questions about gig worker discretionDigital Disruption with Geoff Nielson Discover how technology is reshaping our lives and livelihoods.Listen on: Apple Podcasts SpotifySupport the showEverything Gig Economy Podcast Related: Download the audio podcast Newsletter Octopus is a mobile entertainment tablet for your riders. Earn 100.00 per month for having the tablet in your car! No cost for the driver! Want to earn more and stay safe? Download Maxymo Love the show? You now have the opportunity to support the show with some great rewards by becoming a Patron. Tier #2 we offer free merch, an Extra in-depth podcast per month, and an NSFW pre-show https://www.patreon.com/thegigeconpodcast The Gig Economy Podcast Group. Download Telegram 1st, then click on the link to join. TikTok Subscribe on Youtube

1995 was a launching pad of a year for Brad Pitt, as evidenced by our last two films. First it was the classic "Se7en," and then an Oscar nominated turn in the Uber weird Terry Gilliam directed "12 Monkeys." While we may not have liked the film nearly as much as either of us remembered, 1995 will be remembered as a coming out party for Pitt.Along with some new beers, and trivia, we hope you enjoy this episode more than we enjoyed the film. Thank you for your support, and be sure to find us at 20years4beers.com for more.Support the show

Georgie Jeffreys of Uber and Kelsey Hodgkin of Special Group, LA join me to share the story behind the amazing "Football is for Food" campaign, featuring Matthew McConaughey and so many others. A brilliant episode.

Jobs Job Jobs  - not too hot, not too cold. VIX – under 17 – a contra-signal? The KRI (Key) seems to thing so – overbought at a +5 Guest John Pugliano, host of the Wealthsteading Podcast is our guest.  NEW! DOWNLOAD THE AI GENERATED SHOW NOTES Follow @andrewhorowitz   John Pugliano is the author of The Robots are Coming: A Human's Survival Guide to Profiting in the Age of Automation. He's also the host of the Wealthsteading Podcast where he shares his ideas and personal experience on wealth building principles. John has spent over 30 years studying and applying the habits of financially independent middle-class Americans. His circuitous path to success included serving in the military as both enlisted and officer; a corporate career in industrial sales; and finally a late blooming entrepreneur. John has an M.S. in Systems Management from the University of Southern California and a B.S. in Environmental Science & Engineering from Penn State. Check this out and find out more at: http://www.interactivebrokers.com/ More information available on Horowitz & Company's TDI Managed Growth Strategy Stocks discussed this week - (ABNB), (UBER), (AAPL), (SMR), (OKLO), (CEG), (TSLA), (AMZN), (WMT)